← Back to Clinical Trials
Recruiting NCT04811313

Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Intraoperative Blood Loss
Sponsor Assiut University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 1 Year
Max Age 18 Years
Start Date 2025-04-03
Completion 2026-01
Interventions
Tranexamic acidcaudal epidural blockPlacebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Surgical hip reconstruction reduces the hip joint through soft tissue releases and osteotomies of the femur and/or pelvis. Blood loss and subsequent blood transfusion are normal consequences of hip reconstruction.

Eligibility Criteria

Inclusion Criteria: * ASA I - II * Scheduled for acetabular osteotomy and/or proximal femoral derotation osteotomies. Exclusion Criteria: * Patient's guardian refusal to participate in the study. * Children known to have pre-existing bleeding or coagulation disorders. * Children with anemia; defined according to (WHO ) cutoffs as Hb level\<11g/dl for girls and \<12g/dl for boys * History of epilepsy. * History of renal insufficiency or failure

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE INTRAOPERATIVE BLOOD LOSS TRIALS
}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology